Clinical Trial Results:
A PHASE 2b MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED,
PARALLEL-GROUP, DOSE-RANGING STUDY EVALUATING THE EFFICACY AND SAFETY OF PD 0299685 FOR THE TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE
Estudio en fase 2b multicéntrico, doble ciego, controlado con placebo, con grupos paralelos y de determinación de dosis para evaluar la eficacia y la seguridad de PD-0299685 en el tratamiento de los síntomas vasomotores moderados o intensos asociados a la menopausia.
Summary
|
|
EudraCT number |
2006-001322-25 |
Trial protocol |
ES |
Global completion date |
11 Jul 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
02 Oct 2016
|
First version publication date |
02 Oct 2016
|
Other versions |
|
Summary report(s) |
A4291023 Public Disclosure Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.